Last 981.50 GBp
Change Today -9.00 / -0.91%
Volume 2.2M
SN/ On Other Exchanges
New York
As of 11:35 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

smith & nephew plc (SN/) Snapshot

990.00 GBp
Previous Close
990.50 GBp
Day High
994.00 GBp
Day Low
978.50 GBp
52 Week High
06/5/14 - 1,136 GBp
52 Week Low
10/31/13 - 780.50 GBp
Market Cap
Average Volume 10 Days
0.58 GBp
Shares Outstanding
0.30 GBp
Dividend Yield
Current Stock Chart for SMITH & NEPHEW PLC (SN/)

Related News

No related news articles were found.

smith & nephew plc (SN/) Related Businessweek News

No Related Businessweek News Found

smith & nephew plc (SN/) Details

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company’s Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and trauma and extremities products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company’s Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. Smith & Nephew plc primarily serves medical and surgical treatments and service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.

14,000 Employees
Last Reported Date: 08/1/14
Founded in 1856

smith & nephew plc (SN/) Top Compensated Officers

Chief Executive Officer, Director, Chairman o...
Total Annual Compensation: $4.2M
Chief Financial Officer, Director and Member ...
Total Annual Compensation: $2.0M
Compensation as of Fiscal Year 2013.

smith & nephew plc (SN/) Key Developments

Smith & Nephew Launches EVOS MINI Plating System for Complex Long Bone Fractures

Smith & Nephew launched its new EVOS MINI Plating System for use in complex fractures of the long bones of the arms and legs. Designed specifically for traumatologists, this long-bone-specific system includes the variety of mini, flat plates and screw sizes necessary to address both fracture reduction and short-term fixation while the final, load-bearing repair is being completed. Organized into a single tray, each EVOS MINI Plating System includes three different, color-coded, size modules that offer a variety of up to eight low-profile plate geometries. Along with the plates, each module also offers the instrumentation for implementing the corresponding low-profile screw options for cortical, cancellous and osteopenic bone. With sizes up to 80mm, the system's screws also offer variable-angle locking technology which allows placement of a locking screw up to 15-degrees off-axis.

Smith & Nephew Announces Top-Line Results from Phase 3 Study of HP802-247

Smith & Nephew announced top-line results from a Phase 3 study of HP802-247, a living cell spray-on therapy designed to work with the body's own cells to stimulate healing of venous leg ulcers. HP802-247 did not meet the primary endpoint, namely a statistically significant improvement in healing over placebo, in a randomized, double-blind, vehicle-controlled study in North America. A full analysis of the efficacy data and study methodology is underway and will be completed in the coming months. A second Phase 3 study in the European Union, which is expected to report in 2016, will continue while the programme analysis is completed.

Smith & Nephew to Launch its D-RAD SMART PACK System for Treating Distal Radius Fractures

Smith & Nephew will launch its D-RAD SMART PACK System for treating distal radius fractures at this week's American Society for Surgery of the Hand (ASSH) annual meeting in Boston. The new system - which includes four, complete, single-use, sterile instrument kits containing implants, and a tray of sterile packaged fasteners and templates - allows hospital OR staff to reduce the typical process used for reprocessing traditional plate and screw systems from eight-steps down to two. In addition to the potential cost savings that can result from improved workflow efficiency and reduced downtime for instrument sets, the new system offers the confidence of knowing that every set is complete and free from the types of wear and/or contamination that can result from the improper handling or reprocessing of traditional sets.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SN/:LN 981.50 GBp -9.00

SN/ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Coloplast A/S kr481.00 DKK +0.10
CR Bard Inc $156.97 USD +2.74
Edwards Lifesciences Corp $116.76 USD +11.57
Olympus Corp ¥3,710 JPY +20.00
St Jude Medical Inc $60.47 USD +0.45
View Industry Companies

Industry Analysis


Industry Average

Valuation SN/ Industry Range
Price/Earnings 27.2x
Price/Sales 3.2x
Price/Book 3.4x
Price/Cash Flow 27.0x
TEV/Sales 3.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SMITH & NEPHEW PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at